Organization: Health Canada
Year: 2022
Month: August
Request Number: A-2022-000276
Request Summary: Adverse Drug Reaction (ADR) for Dexilant. Report number: E2B_05168036. ADRs for Entyvio. Report numbers: E2B_05144393, E2B_05201553, E2B_05100649, E2B_05133754. ADRs for Vedolizumab. Report numbers: E2B_05140162, E2B_05186118, E2B_05110558, E2B_05149563, E2B_05182664.
Disposition: Disclosed in part
Number of pages: 258